Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1995 August; 88(8): 446–449.
PMCID: PMC1295298

The value of antegrade stenting for lower ureteric obstruction.


Eleven kidneys in 10 patients (mean age 80 years) presenting over a period of 1 year with obstruction of the lower ureter secondary to malignant obstruction (8 patients), stone disease (1 patient), and bladder wall hypertrophy (1 patient) underwent nephrostomy with subsequent immediate or delayed antegrade stenting. An antegrade placement of the stent was achieved in 10 of the 11 kidneys (90% success). In three cases a combined procedure was performed with cystoscopic assistance. In most cases there was rapid improvement of renal function following stenting. Insertion of ureteric stents in patients admitted to hospital with malignant ureteric obstruction allowed treatment of their renal failure and subsequent discharge without use of permanent external urinary diversion appliances. No significant complications of the procedure were encountered. Medium term follow-up of patients stented for malignant ureteric obstruction suggests that the stents can be left in place without replacement for up to 20 months.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (540K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abramson AF, Mitty HA. Update on interventional treatment of urinary obstruction. Urol Radiol. 1992;14(3):234–236. [PubMed]
  • Mitty HA, Train JS, Dan SJ. Placement of ureteral stents by antegrade and retrograde techniques. Radiol Clin North Am. 1986 Dec;24(4):587–600. [PubMed]
  • Andriole GL, Bettmann MA, Garnick MB, Richie JP. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J Urol. 1984 Feb;131(2):239–241. [PubMed]
  • Zadra JA, Jewett MA, Keresteci AG, Rankin JT, St Louis E, Grey RR, Pereira JJ. Nonoperative urinary diversion for malignant ureteral obstruction. Cancer. 1987 Sep 15;60(6):1353–1357. [PubMed]
  • Mitty HA. Ureteral stenting facilitated by antegrade transurethral passage of guide wire. AJR Am J Roentgenol. 1984 Apr;142(4):831–832. [PubMed]
  • Lee WJ, Patel U. Complications of universal ureteral stent. Cardiovasc Intervent Radiol. 1989 Nov;12(6):329–333. [PubMed]
  • Cardella JF, Castaneda-Zuniga WR, Hunter DW, Hulbert JC, Amplatz K. Urine-compatible polymer for long-term ureteral stenting. Radiology. 1986 Nov;161(2):313–318. [PubMed]
  • Rackson ME, Mitty HA, Lossef SV, Dan SJ, Train JS. Biocompatible copolymer ureteral stent: maintenance of patency beyond 6 months. AJR Am J Roentgenol. 1989 Oct;153(4):783–784. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press